相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Non-Contrast-Enhancing Tumor: A New Frontier in Glioblastoma Research
A. Lasocki et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2019)
Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0
Ian Law et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
The consistency of neuropathological diagnoses in patients undergoing surgery for suspected recurrence of glioblastoma
Matthias Holdhoff et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
Amino Acid PET Imaging of Glioma
Ephraim E. Parent et al.
CURRENT RADIOLOGY REPORTS (2019)
Incidence of Tumour Progression and Pseudoprogression in High-Grade Gliomas: a Systematic Review and Meta-Analysis
Abdul W. Abbasi et al.
CLINICAL NEURORADIOLOGY (2018)
Current state of immunotherapy for glioblastoma
Michael Lim et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Adult Glioma Incidence and Survival by Race or Ethnicity in the United States From 2000 to 2014
Quinn T. Ostrom et al.
JAMA ONCOLOGY (2018)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011-2015
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2018)
Incidence of pseudoprogression in low-grade gliomas treated with radiotherapy
Sophie E. van West et al.
NEURO-ONCOLOGY (2017)
MR perfusion-weighted imaging in the evaluation of high-grade gliomas after treatment: a systematic review and meta-analysis
Praneil Patel et al.
NEURO-ONCOLOGY (2017)
Treatment outcome of patients with recurrent glioblastoma multiforme: a retrospective multicenter analysis
Myra E. van Linde et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
Lomustine and Bevacizumab in Progressive Glioblastoma
Wolfgang Wick et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
The use of amino acid PET and conventional MRI for monitoring of brain tumor therapy
Norbert Galldiks et al.
NEUROIMAGE-CLINICAL (2017)
Differentiation of pseudoprogression and real progression in glioblastoma using ADC parametric response maps
Caroline Reimer et al.
PLOS ONE (2017)
Perfusion MRI in the Evaluation of Suspected Glioblastoma Recurrence
Stella Blasel et al.
JOURNAL OF NEUROIMAGING (2016)
Progressing Bevacizumab-Induced Diffusion Restriction Is Associated with Coagulative Necrosis Surrounded by Viable Tumor and Decreased Overall Survival in Patients with Recurrent Glioblastoma
H. S. Nguyen et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2016)
Advanced MRI increases the diagnostic accuracy of recurrent glioblastoma: Single institution thresholds and validation of MR spectroscopy and diffusion weighted MR imaging
Tomas Kazda et al.
NEUROIMAGE-CLINICAL (2016)
Radiation therapy for glioblastoma: Executive summary of an American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline
Alvin R. Cabrera et al.
PRACTICAL RADIATION ONCOLOGY (2016)
Diffusion and Perfusion MRI to Differentiate Treatment-Related Changes Including Pseudoprogression from Recurrent Tumors in High-Grade Gliomas with Histopathologic Evidence
A. J. Prager et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2015)
Characterization of pseudoprogression in patients with glioblastoma: is histology the gold standard?
Isaac Melguizo-Gavilanes et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Dynamic contrast enhanced T1 MRI perfusion differentiates pseudoprogression from recurrent glioblastoma
Alissa A. Thomas et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Immunotherapy response assessment in neuro-oncology: a report of the RANO working group
Hideho Okada et al.
LANCET ONCOLOGY (2015)
Glioblastoma Treated with Concurrent Radiation Therapy and Temozolomide Chemotherapy: Differentiation of True Progression from Pseudoprogression with Quantitative Dynamic Contrast-enhanced MR Imaging
Tae Jin Yun et al.
RADIOLOGY (2015)
Role of magnetic resonance spectroscopy for the differentiation of recurrent glioma from radiation necrosis: A systematic review and meta-analysis
Hui Zhang et al.
EUROPEAN JOURNAL OF RADIOLOGY (2014)
Maximum Safe Resection of Glioblastoma Multiforme
Michel Lacroix et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Pseudoprogression in patients with glioblastoma: added value of arterial spin labeling to dynamic susceptibility contrast perfusion MR imaging
Young Jun Choi et al.
ACTA RADIOLOGICA (2013)
Diagnostic Accuracy of PET for Recurrent Glioma Diagnosis: A Meta-Analysis
T. Nihashi et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2013)
Prediction of Pseudoprogression in Patients with Glioblastomas Using the Initial and Final Area Under the Curves Ratio Derived from Dynamic Contrast-Enhanced T1-Weighted Perfusion MR Imaging
C. H. Suh et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2013)
MRI perfusion in determining pseudoprogression in patients with glioblastoma
Robert J. Young et al.
CLINICAL IMAGING (2013)
Persistent Diffusion-Restricted Lesions in Bevacizumab-Treated Malignant Gliomas Are Associated with Improved Survival Compared with Matched Controls
S. Mong et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2012)
Pathologic Diagnosis of Recurrent Glioblastoma: Morphologic, Immunohistochemical, and Molecular Analysis of 20 Paired Cases
Jang-Hee Kim et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
Distinction between postoperative recurrent glioma and delayed radiation injury using MR perfusion weighted imaging
Jun-Ling Xu et al.
JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY (2011)
Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas
M. J. van den Bent et al.
LANCET ONCOLOGY (2011)
Molecular imaging of gliomas with PET: Opportunities and limitations
Christian la Fougere et al.
NEURO-ONCOLOGY (2011)
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
Patrick Y. Wen et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Relative Cerebral Blood Volume Values to Differentiate High-Grade Glioma Recurrence from Posttreatment Radiation Effect: Direct Correlation between Image-Guided Tissue Histopathology and Localized Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging Measurements
L. S. Hu et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2009)
Differentiation of Recurrent Glioblastoma Multiforme from Radiation Necrosis after External Beam Radiation Therapy with Dynamic Susceptibility-weighted Contrast-enhanced Perfusion MR Imaging
Ramon F. Barajas et al.
RADIOLOGY (2009)
Arterial spin-labeling in routine clinical practice, part 1: Technique and artifacts
A. R. Deibler et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2008)
Incidence of early pseudo-progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide
Walter Taal et al.
CANCER (2008)
Glioblastoma multiforme: an emerging paradigm of anti-VEGF therapy
David A. Reardon et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2008)
MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients
Alba A. Brandes et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment
AJ Kumar et al.
RADIOLOGY (2000)
分享论文
